Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 3Head & Neck 2Other 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 123Head and Neck Neoplasms 80Oropharyngeal Neoplasms 19Carcinoma, Non-Small-Cell Lung 15Laryngeal Neoplasms 13Carcinoma, Squamous Cell 13Salivary Gland Neoplasms 12Carcinoma 12Mouth Neoplasms 11Ovarian Neoplasms 9Neoplasm Metastasis 9Nasopharyngeal Carcinoma 9Nasopharyngeal Neoplasms 8Esophageal Neoplasms 8Stomach Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Lung Neoplasms 6Hypopharyngeal Neoplasms 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Small Cell Lung Carcinoma 5Recurrence 5Papillomavirus Infections 5Melanoma 5Breast Neoplasms 5Urinary Bladder Neoplasms 4Tongue Neoplasms 4Sarcoma 4Pancreatic Neoplasms 4Esophageal Squamous Cell Carcinoma 4

Interventions

Radiotherapy 15Cisplatin 6Amifostine 5Radiotherapy, Intensity-Modulated 4sargramostim 3Radiation 3Paclitaxel 3Bevacizumab 3Surgical Procedures, Operative 2Chemotherapy, Adjuvant 2Carboplatin 2cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Xylitol 1Vortioxetine 1Tooth Extraction 1Steroids 1Selenomethionine 1Salts 1Saline Solution 1Radiotherapy, Conformal 1Radiography, Panoramic 1Radiation Protection 1Physical Therapy Modalities 1Palonosetron 1Oral Hygiene 1Olanzapine 1Neck Dissection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Radiation Injuries × Carboplatin × Head & Neck × Clear all
NCT00095927 2017-01-04

Randomized Amifostine For SCCHN

Dana-Farber Cancer Institute

Phase 2 Completed
58 enrolled
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Injuries, Xerostomia, Mucositis

NCT00025298 2012-09-24

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
5 enrolled
Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡